These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 11920269
1. Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARalpha fusion transcript in patients with acute promyelocytic leukemia. Gu BW, Hu J, Xu L, Yan H, Jin WR, Zhu YM, Zhao WL, Niu C, Cao Q, Su XY, Gu J, Ying HY, Chen Y, Xiong SM, Shen ZX, Chen Z, Chen SJ. Hematol J; 2001; 2(5):330-40. PubMed ID: 11920269 [Abstract] [Full Text] [Related]
4. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction]. Lang L, Li HM, Liu H, Wang YM, Zhang XM. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789 [Abstract] [Full Text] [Related]
8. Diagnosis and molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR to quantify PML/RARalpha fusion transcripts. Applegate TL, Iland HJ, Mokany E, Todd AV. Clin Chem; 2002 Aug; 48(8):1338-43. PubMed ID: 12142392 [Abstract] [Full Text] [Related]
9. [Improved RT-PCR for detection of PML/RARalpha fusion gene in rapid diagnosis of acute promyelocytic leukemia]. Liu ZL, Luo JM, Wang FX, Zhang XJ, Du XY, Yao L, Dong ZR. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):587-90. PubMed ID: 14706140 [Abstract] [Full Text] [Related]
12. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. Meloni G, Diverio D, Vignetti M, Avvisati G, Capria S, Petti MC, Mandelli F, Lo Coco F. Blood; 1997 Aug 01; 90(3):1321-5. PubMed ID: 9242568 [Abstract] [Full Text] [Related]
13. Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia. Santamaría C, Chillón MC, Fernández C, Martín-Jiménez P, Balanzategui A, García Sanz R, San Miguel JF, González MG. Haematologica; 2007 Mar 01; 92(3):315-22. PubMed ID: 17339180 [Abstract] [Full Text] [Related]
16. Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RARalpha chimeric gene: a retrospective study of clinical feasibility. Suzuki H, Imaizumi M, Sato A, Yoshinari M, Rikiishi T, Endo M, Takano T, Shimizu T, Hatae Y, Fujimoto T, Hayashi Y, Iinuma K. Tohoku J Exp Med; 2001 Feb 01; 193(2):127-39. PubMed ID: 11318028 [Abstract] [Full Text] [Related]
19. Expression of PML-RARα is up-regulated during ATRA and arsenics combined induction without influence on long-term prognosis of acute promyelocytic leukemia. Zhu HH, Qin YZ, Lai YY, Shi HX, Liu YR, Jiang B, Huang XJ. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug 01; 21(4):872-8. PubMed ID: 23998577 [Abstract] [Full Text] [Related]